DigiTx Partners

Mightier is a gaming platform and family program scientifically-proven to help kids regulate their emotions. It is a bioresponsive program that harnesses the mind-body connection to build emotional regulation in its players. Its program of bioresponsive video games, developed at Boston Children's Hospital and Harvard Medical School, aims to help children with behavioral and emotional challenges learn how to harness emotions in daily life. Mightier was founded in 2016 and is headquartered in Boston, Massachusetts.

Rune Labs is a software and data platform for neuromodulation and brain therapies of the future. The platform's software-as-a-service platform works with existing and emerging neuromodulation systems to manage complex therapies and get the most value out of available data. Their cloud-based software platform provides these therapy developers the performance, scalability, and availability they need to run complex therapy algorithms across many patients, deliver precision medicine, and identify likely responders for clinical trials. Rune Labs was founded in 2018 and is headquartered in San Francisco, California.

Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.

Nēsos develops and commercializes electrical field treatments for neurological disorders. It is critically supported by expert clinical and scientific collaborators from leading academic institutions, including Stanford, Vall d'Hebron, Harvard, Mount Sinai, Feinstein Institute, University Of California, San Diego (UCSD), and the University Of California, San Francisco (UCSF). It was co-founded by Konstantinos Alataris and other neuroscientists.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Rune Labs is a software and data platform for neuromodulation and brain therapies of the future. The platform's software-as-a-service platform works with existing and emerging neuromodulation systems to manage complex therapies and get the most value out of available data. Their cloud-based software platform provides these therapy developers the performance, scalability, and availability they need to run complex therapy algorithms across many patients, deliver precision medicine, and identify likely responders for clinical trials. Rune Labs was founded in 2018 and is headquartered in San Francisco, California.

G-Tech Medical is developing a wireless, wearable, disposable electrode patch to measure the electrical activity from the stomach, small intestine and colon. Most patients with abdominal pain, constipation, diarrhea or bloating have functional disorders that are not diagnosed with colonoscopies or CT scans. G-Tech's GutCheck patch will measure motor activity and thus evaluate motility to allow physicians to better target the treatment.

nQ Medical is a digital therapeutics company addressing neurocognitive and neuromotor disorder via 24/7, passive data collection via personal devices. It is a frictionless, non-invasive, early detection, remote disease progression monitoring, and therapeutic measurement modality. nQ uses an artificial intelligence company to develop computational biomarkers that have been proven in five years of clinical trials to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders (Alzhemer's, Parkinson's, Multiple Sclerosis, ALS, concussion, et al. The platfomr focuses on analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders. The fine control of typing and touch screen kinematics together with the frequent use of electronic devices allows for precise monitoring of small changes in neurodegeneration that frequently go unnoticed by clinicians. nQ allows for early detection of disease, 24/7, passive, at home, remote monitoring of disease progression and the measurement of impact of therapy at a fraction of the cost of current gold standards. There is no required task. Just use your device as your would normally use it. Of note, as one of the company's medical advisors, Zoltan Mari, MD, of the Cleveland Clinic, so aptly quoted: "As important as it is to fund novel compounds for treating diseases, it is also important to set the stage for maximum impact when those compounds are discovered and approved for use. It is impossible to find a cure without early detection. That's why drug candidates fail. When the FDA puts its stamp on the first disease modifying drugs, such early detection technologies will be instantly necessary." He goes on to state further: "We also need a disease progression marker. Nothing so far has managed to do very well (while being profoundly expensive). Much of our research and clinical interest is turning toward disease progression. All efforts should focus on readying and perfecting early detection tools and building effective, reliable, inexpensive ways of tracking disease and the impact of therapy over time.” nQ is that early detection, disease progression computational biomarker.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Embr Labs is the first thermal wellness technology company that has harnessed the body’s natural response to temperature to enhance human wellbeing. Embr technology leverages temperature as a new pathway to the brain to balance the autonomic nervous system and helps individuals manage hot flashes, sleep disturbances, and anxiety. Embr Labs has tens of thousands of customers in 170 countries. Our customers have logged over 100M minutes and 6M sessions of thermal interventions. A mobile app and cloud infrastructure augment our wearable, forming a unique technology platform that combines thermal stimulation, digital interventions, and data to manage symptoms and treat disease. The technology was invented by the company’s founders while they were engineering students MIT. Embr Labs is backed by DigiTx Partners, Safar Partners, Joy Ventures, Bose Ventures, Intel Capital and others, and been awarded over $2.5M in grant funding from the NIH, DOD, and Massachusetts Life Sciences Center.

Neosensory focus on sending a variety of data streams to the brain via the sense of touch. With so much unused real estate on the body, the skin presents huge potential for the delivery of new information. They are currently building the world’s first hearing assistive technology that enables people to listen with their skin.

Savonix provides a valid and reliable measurement of cognitive function mapped to real world outcomes in domains like cognitive flexibility and on road performance in aging populations. Their customers include doctors, researchers, Fortune 50 insurance, and governments. Their platform provides users with easy to use and accessible tests of their brain function in multiple domains from memory to implicit learning that they can complete on a smartphone or tablet – guided and reported on by a virtual clinician. This information can in turn be used to understand risk for dementia and other brain disorders, as well as drive precision medicine in treatment planning and diagnosis. Unique to Savonix is their 3D game platform for testing that drives meta-data which has already resulted in the ability to report on the novel cognitive domain of Implicit Learning without adding a test but deriving it from passive in app performance in gold standard measures. Savonix is the only widely available mobile-ready digital cognitive test for early detection of cognitive change that is backed by decades of research into cognitive testing. They didn’t invent the wheel, they made it affordable, accessible, actionable and scalable.

LifeLink is the conversational engagement platform for healthcare. We work with some of the largest healthcare systems and pharma companies in the country to reach their patients on mobile and messaging, with personalized, natural, and contextual conversations. LifeLink chatbots automate thousands of high-value patient touchpoints before, during, and after healthcare visits, resulting in improved operational efficiency, increased customer satisfaction, and superior brand loyalty.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Securely stream patient photographs and wound analysis directly to your desktop! You can now objectively and automatically measure things like chronic wounds, burns, and skin conditions using only a smartphone. Nurses can stream photographs directly to your desktop, where you can evaluate, track, and manage your patients on Their secure web portal.

Siris Medical empowers clinicians to achieve efficient high-quality cancer treatment decisions. It has commercialized the first FDA 510(k) cleared artificial intelligence decision support platform in radiation oncology. It is a member of both the North Shore InnoVentures and the UCSF / QB3 Rosenman incubation programs.

Savonix provides a valid and reliable measurement of cognitive function mapped to real world outcomes in domains like cognitive flexibility and on road performance in aging populations. Their customers include doctors, researchers, Fortune 50 insurance, and governments. Their platform provides users with easy to use and accessible tests of their brain function in multiple domains from memory to implicit learning that they can complete on a smartphone or tablet – guided and reported on by a virtual clinician. This information can in turn be used to understand risk for dementia and other brain disorders, as well as drive precision medicine in treatment planning and diagnosis. Unique to Savonix is their 3D game platform for testing that drives meta-data which has already resulted in the ability to report on the novel cognitive domain of Implicit Learning without adding a test but deriving it from passive in app performance in gold standard measures. Savonix is the only widely available mobile-ready digital cognitive test for early detection of cognitive change that is backed by decades of research into cognitive testing. They didn’t invent the wheel, they made it affordable, accessible, actionable and scalable.

Juji's mission is to democratize the power of artificial intelligence to help move humanity forward. Currently, Juji provides a cloud based software as a service platform for creating Do-It-Yourself AI chatbots. Juji platform integrates the latest advances in artificial intelligence, such as deep learning, natural language processing and machine learning, and makes them usable for non-technical business professionals as part of their daily workflow.

FITNESS & WELLNESS TRACKING MODULES All our platforms offer Bluetooth Smart (Low Energy) wireless, USB charging and data connectivity, Flash memory, and a choice of processing power & of sensors. -Now: 16 bit MCU and gyroscopes, accelerometers, compass, pressure & temperature sensors. -In Q2 2014: 32 bit MCU and, in addition to the above sensors, optional ones such as heart rate, oxygen, humidity, UV, muscle strain, etc.